TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22196620

Group type: EXPERIMENTAL
Intervention: Casein
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pea protein
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Whey
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Egg albumin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Maltodextrin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Water control
Number of subjects: 32
Study: 19380258

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 2 mL lignocaine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Intramuscular injection of 5% hypertonic saline
Number of subjects: 15
Study: 16512941

Group type: EXPERIMENTAL
Intervention: Higher dairy product intake (4th quartile vs. 1st)
Number of subjects: 2776

Group type: EXPERIMENTAL
Intervention: Higher calcium intake (4th quartile vs. 1st)
Number of subjects: 2776

Group type: EXPERIMENTAL
Intervention: Incremental yoghurt consumption (125 g/d)
Number of subjects: 2776
Study: 15369611

Group type: EXPERIMENTAL
Intervention: Non-manual social class
Number of subjects: 3187

Group type: EXPERIMENTAL
Intervention: Transition from manual to non-manual social class
Number of subjects: 3187

Group type: COMPARATOR
Intervention: Manual social class
Number of subjects: 3187
Study: 11503009

Group type: EXPERIMENTAL
Intervention: 300 mg of rifabutin every 7 days (group 1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 150 mg of rifabutin every 3 days (group 2)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 9423997

Group type: EXPERIMENTAL
Intervention: Contact lenses
Number of subjects: 125

Group type: COMPARATOR
Intervention: Spectacles
Number of subjects: 125
Study: 8488716

Group type: EXPERIMENTAL
Intervention: Oral vaccine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Parenteral vaccine
Number of subjects: 30
Study: 2441202

Group type: EXPERIMENTAL
Intervention: Captopril (mean daily dose 84 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 29635857

Group type: COMPARATOR
Intervention: Paracetamol (1000 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Promethazine (50 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Δ9-THC (10 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 28570127

Group type: EXPERIMENTAL
Intervention: Epinephrine autoinjector
Number of subjects: 189

Group type: COMPARATOR
Intervention: Manual delivery of epinephrine
Number of subjects: 189
Study: 26286324

Group type: EXPERIMENTAL
Intervention: Mitii™ training (20 weeks, 30 min per day, six days a week, total dose of 60 hours)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (waitlisted for 20 weeks)
Number of subjects: 60
Study: 23816491

Group type: EXPERIMENTAL
Intervention: Extended release gabapentin (G-ER) up to 3000 mg/d
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Extended release gabapentin (G-ER)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 21359223

Group type: EXPERIMENTAL
Intervention: Congenitally deaf participants
Number of subjects: 43

Group type: COMPARATOR
Intervention: Normal-hearing participants
Number of subjects: 43
Study: 18842157

Group type: EXPERIMENTAL
Intervention: Integrated programme including prehabilitation and early rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care programme
Number of subjects: 60
Study: 17312707

Group type: EXPERIMENTAL
Intervention: Training in diagnostic ultrasound systems (UTS) with hands-on scanning practice
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Diagnostic ultrasound images produced by students
Number of subjects: 37
Study: 14569044

Group type: EXPERIMENTAL
Intervention: Weight alone
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Weight plus age and gender
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Weight plus height, gender, Tanner stage, and abdominal skinfold
Number of subjects: 96
Study: 10965833

Group type: EXPERIMENTAL
Intervention: Pre‐emptive analgesia with bupivacaine infiltrated preoperatively, intraoperatively, and postoperatively
Number of subjects: 70

Group type: COMPARATOR
Intervention: Saline infiltrations at the same times
Number of subjects: 70
Study: 10765339

Group type: EXPERIMENTAL
Intervention: Instructional method (EG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional method (CG)
Number of subjects: 70
Study: 8347073

Group type: EXPERIMENTAL
Intervention: Autotraction (AT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Passive Traction (PT)
Number of subjects: 67
Study: 3760276

Group type: EXPERIMENTAL
Intervention: Topical capsaicin applied to one side of the body
Number of subjects: 44

Group type: COMPARATOR
Intervention: Vehicle applied to the other side of the body
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Topical capsaicin
Number of subjects: 44

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 44
Study: 31828283

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Serum 25(OH) vitamin D
Number of subjects: 100
Study: 28254106

Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moxibustion control or placebo procedure
Number of subjects: 0
Study: 23070104

Group type: EXPERIMENTAL
Intervention: SMART stent
Number of subjects: 150

Group type: COMPARATOR
Intervention: Balloon angioplasty (PTA)
Number of subjects: 150
Study: 21784377

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 5 mg once-weekly (with titration to 10 mg if not at LDL goal at week 4)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 17
Study: 19270639

Group type: EXPERIMENTAL
Intervention: Physiotherapy plus mesoglycan 50 mg p.o., twice a day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 44
Study: 16521017

Group type: EXPERIMENTAL
Intervention: Saline solution containing a low dose of norepinephrine
Number of subjects: 84

Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 84
Study: 15187503

Group type: EXPERIMENTAL
Intervention: 6 mL/kg predicted body weight tidal volume
Number of subjects: 300

Group type: COMPARATOR
Intervention: 12 mL/kg predicted body weight tidal volume
Number of subjects: 300

Group type: COMPARATOR
Intervention: 12.3 +/- 2.7 mL/kg tidal volume
Number of subjects: 300
Study: 10776101

Group type: EXPERIMENTAL
Intervention: Control on Campus intervention program
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 9401573

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment, 1.0 IU/kg/day, subcutaneous injections from postnatal day 7 until body weight of 2000 g (postnatal week 7-8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no GH treatment)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 14
Study: 8397245

Group type: EXPERIMENTAL
Intervention: 80 mmol/24 h sodium supplement
Number of subjects: 17

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low sodium intake
Number of subjects: 17
Study: 2427042

Group type: EXPERIMENTAL
Intervention: Peritoneal lavage
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard care in the ICU
Number of subjects: 39
Study: 31957303

Group type: EXPERIMENTAL
Intervention: CZP + MTX
Number of subjects: 316

Group type: COMPARATOR
Intervention: PBO + MTX
Number of subjects: 316
Study: 29016985

Group type: EXPERIMENTAL
Intervention: Maxcem Elite with etched teeth (Group 1, IME)
Number of subjects: 1098

Group type: COMPARATOR
Intervention: Maxcem Elite with non-etched teeth (Group 2, IMNE)
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: Nexus+Excite (Group 3, INE)
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: Relyx (Group 4, IRE)
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: Maxcem Elite with silicatized base (Group 5, HRME)
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: Maxcem Elite with non-silicatized base (Group 6, HNRME)
Number of subjects: 1098
Study: 25773504

Group type: EXPERIMENTAL
Intervention: LMA-Supreme
Number of subjects: 90

Group type: COMPARATOR
Intervention: i-gel
Number of subjects: 90
Study: 24895454

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (20 mg daily; 15 mg if creatinine clearance <50 mL/min)
Number of subjects: 6229

Group type: COMPARATOR
Intervention: Warfarin (target international normalized ratio=2.0‐3.0)
Number of subjects: 6229
Study: 22005747

Group type: EXPERIMENTAL
Intervention: Exercise training plus usual care (n = 65)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual care alone (n = 33)
Number of subjects: 98
Study: 20546516

Group type: EXPERIMENTAL
Intervention: Single injection PVB followed by CPVB infusion of 0.1% or 0.2% ropivacaine
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 73
Study: 17915572

Group type: EXPERIMENTAL
Intervention: Low dose creatine (60 mg/kg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral sucrose (75 g prior to exercise)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 10
Study: 16264044

Group type: EXPERIMENTAL
Intervention: 1-year smoking cessation in COPD patients
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 1-year smoking cessation in asymptomatic smokers
Number of subjects: 53
Study: 11875168

Group type: EXPERIMENTAL
Intervention: BUD400 (budesonide, 200 microg twice daily via pMDI and NebuChamber)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: FP400 (fluticasone propionate, 200 microg twice daily via pMDI and Babyhaler)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Comparison between BUD400 and FP400
Number of subjects: 40
Study: 10203139

Group type: EXPERIMENTAL
Intervention: 17beta-estradiol (E2) supplementation at 2.30 mg x kg(‐1) x d(‐1) (1.13‐3.42 mg x kg(‐1) x d(‐1)) and progesterone (P) supplementation at 21.20 mg x kg(‐1) x d(‐1) (11.23‐27.36 mg x kg(‐1) x d(‐1))
Number of subjects: 13
Study: 7775364

Group type: EXPERIMENTAL
Intervention: Sertraline (50‐100 mg/day)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Fluoxetine (20‐40 mg/day)
Number of subjects: 286
Study: 1927983

Group type: EXPERIMENTAL
Intervention: Lip bumpers fabricated from stainless steel round wire covered with shrink tubing, activated every 2 to 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Larger prefabricated lip bumpers covered with acrylic shields from canine to canine, activated every 4 to 5 weeks
Number of subjects: 40
Study: 6364678

Group type: EXPERIMENTAL
Intervention: Topical anaesthetic formulation EMLA (lidocaine-prilocaine cream)
Number of subjects: 119
Study: 30902694

Group type: EXPERIMENTAL
Intervention: Brinzolamide
Number of subjects: 165

Group type: COMPARATOR
Intervention: Travoprost
Number of subjects: 165

Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 165
Study: 29247457

Group type: EXPERIMENTAL
Intervention: hMG + MPA + CC
Number of subjects: 320

Group type: COMPARATOR
Intervention: hMG + MPA
Number of subjects: 320
Study: 24132592

Group type: EXPERIMENTAL
Intervention: Mentor mother support programme
Number of subjects: 63
Study: 22626879

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV), n=19
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV), n=18
Number of subjects: 42

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide therapy (ETV and ADV)
Number of subjects: 42
Study: 19608838

Group type: EXPERIMENTAL
Intervention: Dexamethasone 15 mg
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg
Number of subjects: 129
Study: 17524196

Group type: EXPERIMENTAL
Intervention: Patient-delivered partner medication (PDPM)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Patient-based partner referral (PBPR)
Number of subjects: 106
Study: 15235555

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol and remifentanil
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combined sciatic-femoral nerve block
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 120
Study: 11465522

Group type: EXPERIMENTAL
Intervention: Buspirone (10 to 30 mg b.i.d.)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 9471066

Group type: EXPERIMENTAL
Intervention: 1-locking suture loop configuration per suture strand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-locking suture loop configuration per suture strand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-grasping suture loop configuration per suture strand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single locking configuration per strand
Number of subjects: 0
Study: 8190152

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nutritional supplementation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation with exercise
Number of subjects: 100
Study: 3300587

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Chlordiazepoxide
Number of subjects: 61
Study: 29106516

Group type: EXPERIMENTAL
Intervention: Bezlotoxumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26895303

Group type: EXPERIMENTAL
Intervention: HBP telemonitoring system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 24101420

Group type: EXPERIMENTAL
Intervention: High-dose cholecalciferol
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 21861637

Group type: EXPERIMENTAL
Intervention: Subgingivally applied glycine powder air polishing (SubGPAP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Full-mouth glycine powder air polishing (full-mouth GPAP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 30
Study: 20855784

Group type: EXPERIMENTAL
Intervention: Thigh-length stockings
Number of subjects: 3114

Group type: COMPARATOR
Intervention: Below-knee stockings
Number of subjects: 3114
Study: 18216861

Group type: EXPERIMENTAL
Intervention: Early minimal enteral nutrition from day 2 to day 7
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 84
Study: 15989452

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 microg/kg by intravenous infusion (IV)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: IV fentanyl 0.25 microg/kg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Occlusive dressing and IV fentanyl 0.25 microg/kg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Placebo cream and IV fentanyl 0.25 microg/kg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: EMLA cream and IV fentanyl 0.25 microg/kg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Placebo cream and IV fentanyl 0.25 microg/kg with an occlusive dressing
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: EMLA cream and IV fentanyl 0.25 microg/kg with an occlusive dressing
Number of subjects: 160
Study: 14500150

Group type: EXPERIMENTAL
Intervention: Group 3 (25 mL 0.25% bupivacaine and piroxicam 20 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group 1 (25 mL saline)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group 2 (25 mL 0.25% bupivacaine)
Number of subjects: 90
Study: 10909489

Group type: EXPERIMENTAL
Intervention: Operative treatment with supplementary chemotherapy (EEP cycle: Etoposide, Epirubicin, Cisplatin or 5-fluorouracil)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Operative treatment with supplementary chemotherapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (healthy volunteers and patients after ventricular resection due to chronic peptic ulcer disease)
Number of subjects: 33
Study: 8778851

Group type: EXPERIMENTAL
Intervention: Melatonin (MT), 5 mg, 2300 h, D6‐D8
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Bright Light (BL), 2,000 lx, 0800‐1200 h, D7‐D8
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Melatonin + Bright Light (MT+BL)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (P), 2300 h, D6‐D8
Number of subjects: 7
Study: 1734574

Group type: EXPERIMENTAL
Intervention: Rectopexy alone (group 1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Rectopexy with sigmoidectomy (group 2)
Number of subjects: 18
Study: 6716468

Group type: EXPERIMENTAL
Intervention: Brief daily telephone calls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 31206313

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg for 7 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 100
Study: 30030268

Group type: EXPERIMENTAL
Intervention: Platelet transfusion
Number of subjects: 261

Group type: COMPARATOR
Intervention: No platelet transfusion (Control)
Number of subjects: 261
Study: 27639082

Group type: EXPERIMENTAL
Intervention: Exenatide (5 μg)
Number of subjects: 15
Study: 24727815

Group type: EXPERIMENTAL
Intervention: Dexamethasone (6 mg/m2/day)
Number of subjects: 1947

Group type: COMPARATOR
Intervention: Prednisolone (60 mg/m2/day)
Number of subjects: 1947
Study: 22105898

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CCRT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Single chemotherapy
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CCRT
Number of subjects: 68
Study: 20192935

Group type: EXPERIMENTAL
Intervention: Periprostatic local anesthesia with 2% lidocaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Voltaren suppository placed in rectum an hour before biopsy
Number of subjects: 90

Group type: COMPARATOR
Intervention: No local anesthesia
Number of subjects: 90
Study: 18334829

Group type: EXPERIMENTAL
Intervention: ALIRI (pemetrexed 500 mg/m² and irinotecan 350 mg/m²)
Number of subjects: 130

Group type: COMPARATOR
Intervention: FOLFIRI (irinotecan 180 mg/m², leucovorin 200 mg/m², bolus 5-FU 400 mg/m², 5-FU 600 mg/m² infusion)
Number of subjects: 130
Study: 16286517

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times daily for 24 weeks
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 12022381

Group type: EXPERIMENTAL
Intervention: Clopidogrel (Plavix)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9863851

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle changes (10% fat whole foods vegetarian diet, aerobic exercise, stress management training, smoking cessation, group psychosocial support) for 5 years
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 48
Study: 8534620

Group type: EXPERIMENTAL
Intervention: Low dose aspirin (60 mg)
Number of subjects: 4168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4168
Study: 2212376

Group type: COMPARATOR
Intervention: Benazepril
Number of subjects: 29

Group type: COMPARATOR
Intervention: Metoprolol OROS
Number of subjects: 29

Group type: COMPARATOR
Intervention: Combination of benazepril and metoprolol OROS
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 29
Study: 842986

Group type: EXPERIMENTAL
Intervention: Primary biliary cirrhosis patients
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Radiocopper studies in primary biliary cirrhosis patients
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 64Cu in ceruloplasmin study
Number of subjects: 4
Study: 30739385

Group type: EXPERIMENTAL
Intervention: Immediate ART initiation (intervention group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (before intervention)
Number of subjects: 0
Study: 28247406

Group type: EXPERIMENTAL
Intervention: Mitii training programme
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 102
Study: 26265174

Group type: EXPERIMENTAL
Intervention: Participants with prior cancer
Number of subjects: 3336

Group type: COMPARATOR
Intervention: Participants without prior cancer
Number of subjects: 3336
Study: 23138859

Group type: EXPERIMENTAL
Intervention: Lightweight (LW) mesh
Number of subjects: 110

Group type: COMPARATOR
Intervention: Heavyweight (HW) mesh
Number of subjects: 110
Study: 21675889

Group type: EXPERIMENTAL
Intervention: PsA‐TT
Number of subjects: 1501

Group type: COMPARATOR
Intervention: PsACWY
Number of subjects: 1501
Study: 19291356

Group type: EXPERIMENTAL
Intervention: Daily multivitamin tablet containing vitamin D(2) 400 IU (10 microg) for 6 months.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group of age-matched burned children without vitamin D supplementation.
Number of subjects: 8
Study: 17034441

Group type: EXPERIMENTAL
Intervention: MDMA 75 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Methylphenidate 20 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12768070

Group type: EXPERIMENTAL
Intervention: Growth hormone (rHuGH) therapy at a dose of 0.2 IU/kg/BW
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11152056

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment according to TCM principles (n = 20)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (acupuncture points not specific for asthma, n = 18)
Number of subjects: 38
Study: 9359442

Group type: EXPERIMENTAL
Intervention: Colposcopically-directed biopsies
Number of subjects: 2798

Group type: COMPARATOR
Intervention: Anti-inflammatory therapy
Number of subjects: 2798
Study: 8251028

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combination of ranitidine and chlorpheniramine
Number of subjects: 6

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 6
Study: 3765637

Group type: EXPERIMENTAL
Intervention: Iodine brine concentrate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isotonic NaCl (Control)
Number of subjects: 50
Study: 31102000

Group type: EXPERIMENTAL
Intervention: F‐18‐FLT PET/CT
Number of subjects: 52

Group type: COMPARATOR
Intervention: F‐18‐FDG PET/CT
Number of subjects: 52
Study: 29312660

Group type: EXPERIMENTAL
Intervention: Latrines with ESBL-producing microorganisms
Number of subjects: 70

Group type: COMPARATOR
Intervention: Latrines without ESBL-producing microorganisms
Number of subjects: 70